How does vortioxetine differ from conventional SSRIs?

Vortioxetine does not only inhibit serotonin reuptake (like SSRIs) but also directly modulates several 5-HT receptor subtypes (agonism, partial agonism and antagonism at once). This is called multimodal action, and it may explain the benefit on the cognitive symptoms that accompany depression, typically with fewer sexual side effects.

Is vortioxetine available over the counter?

No. Vortioxetine is a prescription antidepressant (Brintellix/Trintellix) that can only be prescribed and supervised by a physician. It is not a dietary supplement, and both dosing and discontinuation should be managed under medical control.

How long does it take to work?

Mood symptoms typically start improving after 1-2 weeks, but the full antidepressant effect can take 4-6 weeks. Thanks to the long half-life of about 66 hours, once-daily dosing is sufficient.

ApprovedFDA approvedStrong evidence

Vortioxetine

Name: Vortioxetine
Creator: MolekulaX

Multimodal serotonin modulator antidepressant (Rx), a modern MDD drug that also targets cognitive symptoms.

AntidepressantSerotonin modulatorAntidepressantMoodSerotoninDopaminenoo.affects.moodnoo.affects.memory

Available at

PCTZONE-10% coupon: MOLEKULAX

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassAntidepressant · Mood

Primary targetSerotonin transporter (SERT) inhibition + multimodal 5-HT receptor modulation

Targets4 receptor targets

Half-lifeAbout 66 hours, which allows once-daily dosing

OnsetDepressive symptoms typically begin improving after 1-2 weeks, with full effect taking 4-6 weeks

EvidenceStrong evidence

Affected systemsSerotoninDopaminenoo.affects.moodnoo.affects.memory

Contents

WHAT IS VORTIOXETINE?

Detailed overview

Vortioxetine (Lu AA21004, marketed as Trintellix/Brintellix) is a prescription multimodal serotonin modulator antidepressant approved for major depressive disorder (MDD) in adults. It simultaneously inhibits the serotonin transporter (SERT) and directly modulates several 5-HT receptor subtypes: it is an agonist at 5-HT1A, a partial agonist at 5-HT1B, and an antagonist at 5-HT3, 5-HT7 and 5-HT1D. This receptor profile secondarily influences the release of noradrenaline, dopamine, acetylcholine, histamine and glutamate in brain regions governing mood and cognition. Beyond mood improvement, clinical trials have shown benefit for the cognitive symptoms of depression (processing speed, executive function), with lower rates of sexual side effects than conventional SSRIs.

Mechanism

SERT inhibition + multimodal 5-HT receptor modulation

Half-life

~66 hours (once-daily dosing)

Legal status

Prescription antidepressant (FDA/EMA approved)

Receptor profile

Serotonin transporter (SERT)Strong
5-HT3 / 5-HT7 / 5-HT1D receptor antagonismStrong
5-HT1A receptor agonismModerate
5-HT1B receptor partial agonismModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

Nausea, the most common side effect, typically in the first weeks of treatment and gradually easing
Diarrhea, constipation or vomiting, usually mild and transient
Dizziness, dry mouth and itching
Sexual dysfunction, though typically to a lesser degree than with conventional SSRIs
Hyponatremia (low blood sodium), especially in the elderly and those on diuretics
Rarely serotonin syndrome, especially combined with other serotonergic agents

Contraindications · 5

Co-administration with MAO inhibitors is contraindicated due to serotonin syndrome risk (14-day washout required)
Known hypersensitivity to vortioxetine or any excipient of the product
Extra caution in patients under 25 due to the early risk of suicidal ideation (class effect)
History of mania/hypomania or bipolar disorder: an antidepressant may trigger a mood switch
Pregnancy and breastfeeding: only after clear benefit-risk assessment under medical supervision

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

J Clin Psychiatry. 2017

Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder

McIntyre RS, Florea I, Tonnoir B, Loft H, Lam RW, Christensen MC

PMID: 27780334Open

J Sex Med. 2015

Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction

Jacobsen PL, Mahableshwarkar AR, Chen Y, Chrones L, Clayton AH

PMID: 26331383Open

Int Clin Psychopharmacol. 2012

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

Katona C, Hansen T, Olsen CK

PMID: 22572889Open

Exp Ther Med. 2023

Efficacy and safety of vortioxetine (Lu AA21004) in the treatment of adult patients with major depressive disorder

Gao S, et al.

PMID: 37840562Open

Expert Opin Drug Saf. 2015

Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder

Al-Sukhni M, Maruschak NA, McIntyre RS

PMID: 26022537Open

FAQ

Multimodal serotonin modulator antidepressant (Rx), a modern MDD drug that also targets cognitive symptoms.

Have a question about Vortioxetine?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAntidepressant

FormulaC18H22N2S

UpdatedJuly 10, 2026

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA

Updated: July 10, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.